Home > Financial Ratios > SUDEEP PHARMA

SUDEEP PHARMA
Core EBITDA Growth

    Back to All Ratios
SUDEEP PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUDEEP PHARMA
Please provide your vote to see the results

SUDEEP PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 25.486.2489.1733.1857.50

What is the latest Core EBITDA Growth ratio of SUDEEP PHARMA ?

The latest Core EBITDA Growth ratio of SUDEEP PHARMA is 25.48 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202625.48
Mar20256.24
Mar202489.17
Mar202333.18
Mar202257.50

How is Core EBITDA Growth of SUDEEP PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2026 25.48
308.33
Mar2025 6.24
-93.00
Mar2024 89.17
168.75
Mar2023 33.18
-42.30
Mar2022 57.5 -

Other Financial Ratios of SUDEEP PHARMA


Compare Core EBITDA Growth ratio of peers of SUDEEP PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUDEEP PHARMA ₹12,561.3 Cr 0.5% 30.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


SUDEEP PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUDEEP PHARMA

0.5%

30.7%

NA
SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses